APA (7th ed.) Citation

Liu, W., Feng, P., Cheng, C., Chou, C., Lee, C., Lu, M., . . . Sheng, W. (2024). A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19. Infectious Diseases and Therapy, 13(7), 1575. https://doi.org/10.1007/s40121-024-00992-5

Chicago Style (17th ed.) Citation

Liu, Wang-Da, et al. "A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19." Infectious Diseases and Therapy 13, no. 7 (2024): 1575. https://doi.org/10.1007/s40121-024-00992-5.

MLA (9th ed.) Citation

Liu, Wang-Da, et al. "A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19." Infectious Diseases and Therapy, vol. 13, no. 7, 2024, p. 1575, https://doi.org/10.1007/s40121-024-00992-5.